| Literature DB >> 18629924 |
M S Sinacore1, T S Charlebois, S Harrison, S Brennan, T Richards, M Hamilton, S Scott, S Brodeur, P Oakes, M Leonard, M Switzer, A Anagnostopoulos, B Foster, A Harris, M Jankowski, M Bond, S Martin, S R Adamson.
Abstract
Using an adaptive strategy, Chinese hamster ovary (CHO) cell lines were developed that are capable of robust growth in serum-free suspension culture. These preadapted derivatives of the commonly used strain of CHO cells (CHO DUKX), termed PA-DUKX, were used for the introduction and stable expression of several heterologous human genes. A significant advantage of recombinant PA-DUKX cells was their ability to readily resume growth in serum-free suspension culture after transfection and amplification of heterologous genes. Expression of recombinant human proteins in PA-DUKX cells was quantitatively similar to that of lineages generated using conventional CHO DUKX cells. In addition, recombinant human proteins expressed by transfected PA-DUKX lineages were shown to be biochemically and structurally similar to those expressed in CHO DUKX cells, PA-DUKX host cell technology provides an opportunity for reducing the time and resources required to develop large-scale, suspension culture-based manufacturing processes employing serum-free medium. (c) 1996 John Wiley & Sons, Inc.Entities:
Year: 1996 PMID: 18629924 DOI: 10.1002/(SICI)1097-0290(19961120)52:4<518::AID-BIT7>3.0.CO;2-S
Source DB: PubMed Journal: Biotechnol Bioeng ISSN: 0006-3592 Impact factor: 4.530